Investigational Site Number :7920012

Izmir 35340

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) — Stopped early